Invitrogen Targets Mass Spec Market In Co-Marketing Pact with Rival ABI | GenomeWeb

Aiming to expand its reach to mass spectrometry users, Invitrogen has launched a line of proteomics kits and reagents and has partnered with life-science rival Applied Biosystems to co-market products to the mass spec market.

The alliance is the latest in a series of acquisitions and partnerships that have pushed Invitrogen into new markets and set the stage for what the company hopes will be significant revenue growth both near and long term.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.